Health Evofem Biosciences to Report Second Quarter 2022 Results and Provide Corporate Update on Thursday, August 4, 2022 August 1, 2022
Health Evofem Biosciences Discusses Innovative Woman-Controlled Contraceptive with The Stock Day Podcast August 1, 2022
Health Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering Potentiated Intranasal Oxytocin (TNX-1900) for the Treatment of Pain August 1, 2022
Health Evofem Announces Completion of Last Subject Last Visit (LSLV) in Registrational Phase 3 “EVOGUARD” Trial Evaluating Phexxi® for the Prevention of Chlamydia and Gonorrhea in Women August 1, 2022
Biotech Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation August 1, 2022
Biotech BridgeBio Pharma Announces Positive Interim Results from a Phase 2 Trial of Infigratinib in Achondroplasia Demonstrating an Increase in Annualized Height Velocity of 1.52 cm/year in Children 5 Years of Age and Older, and Adds 5th Cohort to Trial August 1, 2022
Biotech Iovance Biotherapeutics to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 4, 2022 August 1, 2022